Lloyd Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.4K Sell
32
-288
-90% -$294K 0.01% 259
2026
Q1
$294K Buy
320
+281
+721% +$285K 0.08% 114
2025
Q4
$41.9K Buy
+39
New +$37.3K 0.02% 257
2024
Q2
– Sell
-2,485
Closed -$1.93M – 151
2024
Q1
$1.93M Buy
2,485
+1,970
+383% +$1.4M 0.41% 31
2023
Q4
$300K Sell
515
-1,202
-70% -$702K 0.14% 86
2023
Q3
$922K Buy
+1,717
New +$885K 0.3% 75
2022
Q2
– Sell
-161
Closed -$46K – 343
2022
Q1
$46K Buy
+161
New +$41.4K 0.02% 239
2020
Q1
– Sell
-16
Closed -$2K – 350
2019
Q4
$2K Buy
+16
New +$1.85K ﹤0.01% 306

Other funds holding LLY

Lloyd Advisory Services's LLY Position: Q2 2026 in Review

Lloyd Advisory Services reduced its Eli Lilly (LLY) stake by 90% in Q2 2026, selling an estimated $294K and leaving 32 shares worth $38.4K. The position accounts for 0.01% of the portfolio, ranked #259.

Lloyd Advisory Services first reported a position in LLY in Q4 2019 and has held it in 8 quarters since. The position peaked at $1.93M in Q1 2024. 4,645 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Lloyd Advisory Services held 32 shares of Eli Lilly worth $38.4K as of Q2 2026.
  • Lloyd Advisory Services sold 288 Eli Lilly shares in Q2 2026, an estimated $294K.
  • Eli Lilly made up 0.01% of Lloyd Advisory Services's portfolio in Q2 2026, its #259 holding.
  • Lloyd Advisory Services first reported a position in Eli Lilly in Q4 2019 and has held it in 8 quarters since.
  • Lloyd Advisory Services's Eli Lilly position peaked at $1.93M in Q1 2024.
  • 4,645 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Lloyd Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.